NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/04/2026
Voltar para busca
Dado oficial do USPTO
NCOUNTER SPRINT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NCOUNTER SPRINT
ST13
US500000086357017Classe
1, 5, 9
Pedido
86357017
Registro
5124745
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
28/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
04/08/2014
Data de registro
17/01/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/04/2026
Última transação
28/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2015-09-00
Primeiro uso no comércio
2015-09-00
Código do desenho
4
Tipo de titular
03
Localização do titular
BILLERICA, MA, US
Examinador
REEVES, APRIL ELIZABETH
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BRUKER SPATIAL BIOLOGY, INC.
NanoString Technologies, Inc.
Representantes
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagentsslidessolid matrix materialsmicrofluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory usereagents for proteomicsRNA transcription and microRNA expression profilingsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectorsreagents for scientific or medical research usediagnostic preparations and reagents for scientific or research usesRNA transcription profilingproteomicsclinical diagnosticsenvironmental monitoringbiosurveillanceagricultural inspectionforensic testing of samples containing microorganisms or human fluidssmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; test kitsconsisting of chemical preparations for scientific purposesin particular for the detectiondiagnosisprogress monitoring and progress prediction of diseasesincluding inflammationsinfectionsdisorders of the central nervous systemscardiovascularneurologicalendocrineautoimmune and genetic disorders and cancers; assaysreagentsenzymespolymerasesbuffers and nucleotideskits comprised thereofall for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectorsdiagnostic reagents for scientific in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing
Classe 5
diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogenscomprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samples detecting the presence of analytes in samples and identifying sample typesold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profilingproteomicssmall molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health caremedical diagnostic reagents and diagnostic reagents for clinical or medical laboratory usediagnostic reagents for medical in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Classe 9
computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific researchfor collectingprocessingtaking images of data in connection with scientific or medical researchthe use of diagnostic preparations and reagents for scientific or research useRNA transcription and microRNA expression profilingproteomicsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsanalysis of functional pathway gene setsmonitoring of biofuel productionprognosticpredictiveclinicaloncologyhematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipmentfluidics stationshybridisation ovenscartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquireanalyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functionsfor capturing fluorescent signalsfor extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research usefor use in detecting the presence of analytes in samples and identifying sample typecomprising equipment for screening samplesdetecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devicesreportstest resultsresearch materialworksheets and other non-printed documents and publicationsall being downloadable
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/04/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/04/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
29/01/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
17/01/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/07/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
29/06/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
29/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/06/2022
E815
TEAS SECTION 8 & 15 RECEIVED
25/01/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
17/01/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
17/01/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13/12/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/12/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/11/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
17/11/2016
EX2G
SOU EXTENSION 2 GRANTED
17/11/2016
IUAF
USE AMENDMENT FILED
07/11/2016
EXT2
SOU EXTENSION 2 FILED
07/11/2016
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2016
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/06/2016
EX1G
SOU EXTENSION 1 GRANTED
09/06/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/06/2016
EXT1
SOU EXTENSION 1 FILED
13/05/2016
EEXT
SOU TEAS EXTENSION RECEIVED
13/05/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/11/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/09/2015
PUBO
PUBLISHED FOR OPPOSITION
22/09/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/08/2015
ALIE
ASSIGNED TO LIE
12/08/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/07/2015
NREV
NOTICE OF REVIVAL - E-MAILED
12/07/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2015
PETG
PETITION TO REVIVE-GRANTED
10/07/2015
PROA
TEAS PETITION TO REVIVE RECEIVED
10/07/2015
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
22/06/2015
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
22/06/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/11/2014
GNRT
NON-FINAL ACTION E-MAILED
24/11/2014
CNRT
NON-FINAL ACTION WRITTEN
24/11/2014
DOCK
ASSIGNED TO EXAMINER
17/11/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
14/08/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/08/2014
NWAP
NEW APPLICATION ENTERED
07/08/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NCOUNTER SPRINT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.